Your Article Summary
See Latest ArticlesOptimal timing of radical cystectomy for patients with T1 bladder cancer
Urologic Oncology: Seminars and Original Investigations, 07/01/09
Bochner BH - Radical cystectomy for T1 disease is associated with an excellent survival; however, the optimal timing of radical cystectomy remains one of the more difficult clinical dilemmas in the management of patients with bladder cancer. This article reviews the various features associated with an increased risk of disease progression to provide a framework for optimizing the timing of radical cystectomy.
Related Articles
Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
World Journal of Urology, 10/26/09
Relevance Score: 69%
Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients
BJU International, 11/09/09
Relevance Score: 67%
Fast Track Program in Patients Undergoing Radical Cystectomy: Results in 362 Consecutive Patients
Journal of the American College of Surgeons, 10/30/09
Relevance Score: 67%
Aggregate Lymph Node Metastasis Diameter and Survival After Radical Cystectomy for Invasive Bladder Cancer
Urology, 10/21/09
Relevance Score: 66%
Prognostic Significance of Hydronephrosis in Bladder Cancer Treated by Radical Cystectomy
Urologia Internationalis, 10/20/09
Relevance Score: 66%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
A MicroRNA expression profile defining the invasive bladder tumor phenotype
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Combination of vesicoureteric reflux and vesicoureteric junction obstruction
Scandinavian Journal of Urology and Nephrology, 12/18/09
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
Advances in Urology, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09